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Schuessler, Gaynor, IshiiObjective: The Cox maze III procedure has excellent long-term efficacy in
curing atrial fibrillation. It has not been widely practiced because it is techni-
cally challenging and requires prolonged cardiopulmonary bypass. The aim of
this study was to examine a simplified Cox maze III procedure that uses bipolar
radiofrequency energy as an ablative source.
Methods: Beginning January 2002, a total of 40 consecutive patients underwent
a modified Cox maze III procedure with bipolar radiofrequency energy. Nine-
teen had a lone maze procedure and 21 had a maze procedure plus a concom-
itant operation. One month after the operation, the first 8 patients were inves-
tigated with high-resolution magnetic resonance imaging. Patients were
followed up monthly with clinical examination and electrocardiography.
Results: There was no operative deaths. The crossclamp times were 47  26
minutes for the modified lone Cox maze III procedure and 92  37 minutes for the
Cox maze III procedure plus concomitant procedures. These were significantly
shorter than our previous times for the traditional Cox maze III procedure (93  34
minutes and 122  37 minutes, respectively, P  .05). Follow-up magnetic
resonance imaging showed no evidence of pulmonary vein stenosis, and atrial
contractility was preserved in all patients. There were no late strokes. At 6-month
follow-up, 91% of patients (21/23) were in sinus rhythm.
Conclusions: Bipolar radiofrequency ablation can be used to replace the surgical
incisions of the Cox maze procedure. This energy source did not result in pulmonary
vein stenosis. The modification of the Cox maze III procedure to use bipolar
radiofrequency ablation simplified and shortened this procedure without sacrificing
short-term efficacy.
Atrial fibrillation (AF), the most common sustained cardiac arrhyth-mia, affects as much as 6% of the population older than 65 years.1It is estimated that 1.4 million outpatient hospital visits and227,000 hospitalizations occur annually for the treatment of AF.2Anticoagulation, rate control, antiarrhythmic drugs, cardiover-sion, and catheter ablation therapy all play a role in the treatment
of this arrhythmia, but all of these strategies have had limited success.
The Cox maze procedure was introduced 15 years ago by James Cox for the
o,amiansurgical treatment of refractory AF. It was hypothesized that this operation would
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sible for its maintenance. This result was achieved by cre-
ating conduction block with transmural surgical incisions.
Since its introduction, the operation has undergone two
modifications. The Cox maze III procedure (CMP) is the
most recent version and has had an impressive success rate
of more than 95% at 10 years.3 The late stroke rate in our
series has been less than 1%, with only 1 reported event
among more than 200 consecutive patients. Normally, such
success would have resulted in rapid adoption of a surgical
procedure. However, implementation has been slowed by its
perceived invasiveness and difficulty. The traditional “cut
and sew” technique requires cardiopulmonary bypass and
can be time-consuming. This has resulted in a hesitation by
many surgeons to combine this procedure with valve repair
or replacement. Furthermore, significant morbidity has been
reported, including pacemaker requirement and left atrial
dysfunction.4,5
Simplification of the CMP by eliminating the traditional
cut and sew approach has been proposed as a way to
increase the adoption of this curative operation. Surgical
investigators have used a variety of different energy sources
to create lines of ablation to replace several, and in some
instances all, of the myriad incisions of the CMP. Radio-
frequency (RF) energy has frequently been used in the
ablation of cardiac tissue.6-8 It is capable of producing
myocardial necrosis when applied to either the endocardium
or epicardium. Unipolar RF energy, however, has been
unable to consistently produce transmural lesions. Because
the energy is unfocused, it also has the potential for un-
wanted collateral damage.9-12 To overcome these shortcom-
ings, we have investigated a unique bipolar RF device. The
RF energy is delivered between two closely approximated
1-mm electrodes embedded in the jaws of the clamp. By
measuring the drop in conductance, transmurality of abla-
Figure 1. Modified Cox maze lesion set used in trial. IVC, Inferior
vena cava; SVC, superior vena cava.tion can be measured on-line and used to control the time of
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eliminating the possibility of collateral tissue injury.13-15
After extensive experimental evaluation, a prospective clin-
ical trial was undertaken to examine the effectiveness of the
bipolar RF device to replace some of the cut and sew lesions
in the CMP. The objectives of this modification of the CMP
were to simplify the procedure and reduce operating time
while retaining the efficacy and safety of the procedure.
Patients and Methods
From January 2002 to October 2003, a total of 40 consecutive
patients underwent a modified CMP with a bipolar RF device
(AtriCure, Inc, Cincinnati, Ohio). More than half of the incisions
of the CMP were replaced with RF ablation lines, and the device
was used to individually isolate the right and the left pulmonary
veins (Figure 1). This simplified the procedure by reducing the
number of atrial incisions to two on the right atrium and one on the
left atrium, plus amputation of the left atrial appendage. All of the
procedures were performed by one surgeon (R.J.D.). Approval for
this study was granted by the institutional review board at the
Washington University School of Medicine in St Louis. Informed
consent and approval for release of information were received
from each patient.
The bipolar RF device used in this study consisted of a hand
piece and a RF generator (Figure 2). The generator was capable of
controlling both the voltage and the current delivered to the elec-
trodes in the hand piece. A laptop computer with LabView version
5.1 (National Instruments Corporation, Austin, Tex) was used to
monitor and record temperature, time, current, voltage, impedance,
conductance, and energy continuously during ablation. The tem-
perature of the myocardium was recorded 1 mm from the electrode
edge. These variables were displayed in a continuous graphic
format in real time.
The target tissue to be ablated was clamped between the jaws
of the device. The bipolar electrodes embedded in the jaws were 5
cm long and 1 mm wide. The RF energy was delivered at 75 V and
750 mA. Ablation was begun and continued until tissue conduc-
tance between the two electrodes decreased and achieved a stable
minimum value for 2 seconds. This drop in conductance was used
as an indicator of complete transmural ablation. Electrical isolation
of the pulmonary veins was confirmed in all instances by pacing,
before and after ablation, with a specially designed handheld
bipolar pacing probe.
Technique of the Modified Maze Procedure
After induction of anesthesia, the patients were placed on cardio-
pulmonary bypass with bicaval cannulation. Initially, temperature
was maintained at 36°C to encourage sinus rhythm and allow
accurate determination of pacing thresholds. The left and right
pulmonary veins were dissected and surrounded with umbilical
tape. Patients in AF were electrically cardioverted. Pacing thresh-
olds were recorded from the right and the left pulmonary veins.
The bipolar RF device was then placed around first the right and
then the left pulmonary vein (Figure 3). The device was clamped
twice to ensure complete encirclement of both the superior and the
inferior veins. Occasionally, in patients with large pulmonary
veins, it was necessary to clamp each vein separately. Electrical
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mA. Further ablations were performed if necessary until there was
documented conduction block.
The right atrial lesions of the modified CMP were then per-
formed. As opposed to the traditional CMP, our current modifica-
tions preserve the right atrial appendage. Two of the right atrial
lesions were replaced with bipolar RF ablation lines. The right
atrial free wall lesion from the right atrial appendage was made by
bipolar ablation, as was the lesion between the inferior and the
superior venae cavae (Figures 1 and 4; online-only video). Except
for the isolation of the pulmonary veins, all ablations were done
with a single application.
After completion of the right atrial lesions, a retrograde car-
dioplegia catheter was placed under direct vision into the coronary
sinus. The heart was arrested with a combination of antegrade and
retrograde cold blood cardioplegia. A standard left atriotomy was
performed below the interatrial groove and extended inferiorly
around the right inferior pulmonary vein (Figure 5). It was critical
that this incision intersected the encircling right pulmonary vein
ablation. The transseptal incision of the CMP was replaced with a
bipolar RF ablation across the atrial septum onto the fossa ovalis.
Figure 2. Bipolar RF device (AtriCure, Inc, Cincinnati, Ohio).
Figure 3. Bipolar RF clamp around left pulmonary veins.The atriotomy was extended inferiorly across the posterior left
The Journal of Thoraciatrial free wall in the direction of the mitral valve annulus to
approximately the midpoint of the P2 scallop of the posterior
leaflet of the mitral valve. This incision was carried down to the
atrioventricular groove and then extended endocardially with a
scalpel toward the mitral annulus. This endocardial incision
crossed the coronary sinus, and care was taken to avoid injury. The
coronary sinus was cryoablated at60°C with a 15-mm cryoprobe
(Frigitronics Cardiac Cryosurgical System, Trumbull, Conn). The
retrograde cardioplegia cannula was pulled back during this por-
tion of the procedure. A separate 3-mm cryolesion was placed
Figure 4. Left atrium with left-sided maze lesions.
Figure 5. Four-chamber view of heart with MRI 1 month after
modified CMP.adjacent to the mitral valve annulus. A bipolar RF ablation was
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ing into the left inferior pulmonary vein (Figure 5). The left
atriotomy was closed with a running monofilament suture. The
heart was retracted, and the left atrial appendage was amputated. A
final bipolar RF ablation was performed between the left atrial
appendage and the left superior pulmonary vein. The left atrial
appendage was then oversewn. The aorta was unclamped, and the
right atrial lesions were closed during rewarming.
After the operation, all patients were monitored continuously
for arrhythmias. Perioperative AF was treated with either intrave-
nous or oral amiodarone. If the drug was not tolerated, patients
were managed with rate control medication and elective cardio-
version at 2 to 6 weeks.
One month after discharge from the hospital, the first 8 patients
underwent magnetic resonance imaging (MRI) to assess for pul-
monary vein stenosis and atrial function. Follow-up electrocardio-
grams were obtained at 1, 3, and 6 months for all patients. All
patients reporting palpitations or with documented atrial arrhyth-
mias by electrocardiography underwent 24-hour Holter monitor-
ing.
MRI Imaging Protocol
Subjects were placed supine in a clinical 1.5-T MRI scanner (NT
Inter CV; Philips Medical Systems, Best, The Netherlands) The
imaging protocol comprised multiple anatomic and functional cine
images and multiple velocity-encoded images. The cine images,
prospectively triggered to each R-wave peak, were based on a
steady-state gradient echocardiographic technique, balance fast
field echo. Vertical long-axis cine images were obtained by align-
ing the left ventricular apex with the center of the mitral valve.
From this vertical long-axis image, the horizontal long-axis plane
was aligned through the midpoint of the left ventricular apex and
the mitral valve. A diastolic image at end-expiration provided the
reference image from which a stack of contiguous short-axis slices
was positioned. Slice thickness was 9 mm, and it took 8 to 10
slices to completely traverse the entire left atrium. The typical field
of view was 288  360 mm with matrix size 154  256, giving a
typical reconstructed pixel size of approximately 1.5  1.2 mm.
Quantitative Flow Study
Transmitral and transtricuspid blood flows were assessed with
velocity-encoded MRI.16 Imaging was centered on the mitral valve
plane, with the velocity-encoded imaging slice being 7 mm thick.
Images were acquired at 15 to 20 phases during the cardiac cycle,
depending on the heart rate. Retrospective gating was used to
acquire data for 20% longer than the expected R-R interval.
Data Analysis
Analysis of the acquired images was performed off-line with a
commercial software package (EasyVision release 5, Philips Med-
ical System). The volume of the left atrium was assessed by
planimetry.
Analysis of quantitative flow study was performed by examin-
ing the velocity-encoded images at all time points. The peak
velocity data from within these regions of interest were used to
construct a velocity versus time curve, from which E and A waves
could be identified. The data was then exported to a spreadsheet
format for further data analysis. MRI images were used to assess
538 The Journal of Thoracic and Cardiovascular Surgery ● Octoanatomic and physiologic flow patterns in the pulmonary venous
system. Basic cine images were used to define pulmonary venous
anatomy in the short axis view. Velocity-encoded MRI images




The indications for surgery in this group included arrhyth-
mia intolerance (n  8), antiarrhythmic drug failure (n 
20), recurrent thromboembolism (n  2), and concomitant
cardiac procedures (n  10). The male/female ratio was
23:17. The mean age was 62 12 years. The mean duration
of AF was 6.6  6.8 years. The median duration was 3.8
years (0.5-28 years). Twenty-five patients had paroxysmal
AF, and 15 patients had persistent AF. In 35 of 40 patients
(87%) the AF was permanent. Nineteen patients underwent
a lone maze procedure and 21 patients underwent the maze
procedure with another concomitant cardiac operation. In
this later group, 9 patients underwent the maze procedure
plus mitral valve repair or replacement, 5 patients under-
went the maze procedure plus coronary artery bypass graft-
ing, and 3 patients underwent the maze procedure with
coronary artery bypass grafting and a mitral valve repair.
Pulmonary Vein Isolation
Pacing thresholds for the right and left pulmonary veins
were 0.9 1.0 mA and 1.1 1.6 mA, respectively. The left
and right pulmonary veins were isolated in every instance,
as documented by pacing at 20 mA. The right pulmonary
veins underwent an average of 3.0  1.2 RF applications,
whereas the left pulmonary veins underwent 3.1  1.3 RF
applications. The mean total ablation times were 28  13
seconds for the right pulmonary veins and 28  12 seconds
for the left pulmonary veins.
Perioperative Results
The mean RF ablation time was 9.5  3.8 seconds for each
application. The mean crossclamp time was 54  27 min-
utes for the lone modified CMP. In comparison, the cross-
clamp time for lone traditional CMP was 93  34 minutes
(P  .001). For the concomitant procedure, the average
crossclamp time was 99  30 minutes. In the traditional
concomitant procedure group, the crossclamp time was 123
 36 minutes (P  .005).
The median intensive care unit stay was 2 days. The
median hospital stay was 12 days.
Postoperative Complications
There were no operative deaths. Five patients had reexplora-
tion for mediastinal bleeding. There were no strokes or
sternal infections. Postoperative AF was present in 25 pa-
tients (63%), but this was usually transient. Thirty-four
patients (85%) were discharged from the hospital in normal
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permanent pacemaker placement for sick sinus syndrome.
There were no complications attributable to the bipolar
device in terms of collateral tissue injury.
MRI Results
MRI studies were conducted on the first 8 patients 4 to 6
weeks after operation. There was no evidence of pulmonary
vein stenosis or thrombosis in any patient (Figure 6). Atrial
contractility, as documented by the presence of an A wave
on the transmitral flow trace, was preserved in all patients.
Arrhythmia Control
The mean follow-up time was 8.1  5.5 months. Median
follow-up was 6 months. At 1 month after the operation, 27
of 38 patients (71%) were free from AF. At 3 months and 6
months, 28 of 33 patients (85%) and 21 of 23 patients
(91%), respectively, were free from AF. At last follow-up,
37 of 40 patients (93%) were free from AF. A significant
decline in the number of patients requiring antiarrhythmic
drug therapy was observed during a 6-month period; 32 of
40 patients (80%) required therapy at discharge versus 10 of
23 patients (44%) at 6-month follow-up.
Discussion
The Cox maze procedure was developed to restore normal
sinus rhythm, allow for the discontinuation of anticoagula-
tion and antiarrhythmic drugs, and reduce stroke risk.17,18
The final iteration of this operation, the CMP, was intro-
duced in 1988. Between January 1988 and January 2002, a
total of 198 consecutive patients underwent the CMP at
Barnes-Jewish Hospital.19 The freedom from recurrent AF
at 14 years was 93% for the entire group. The excellent
long-term results with this operation established it as the
Figure 6. Freedom frocriterion standard for the surgical treatment of AF.
The Journal of ThoraciDespite these excellent results, the CMP had shortcom-
ings. Although mortality rates remained low (1.5% in our
series), there was significant morbidity. The operation re-
quired a relatively long period of cardiopulmonary bypass
and an arrested heart. At our institution, the average cross-
clamp time to perform a lone maze procedure was 93  34
minutes. After CMP, 15% of the patients required postop-
erative pacemakers. The median stay was 9 days after a lone
CMP and 12 days after a CMP concomitant with other
surgery. Finally, left atrial dysfunction has been noted in
many patients.4,20,21
These problems with the traditional CMP have led our
group and others to begin evaluating strategies to simplify
the surgical treatment of AF.22,23 A common strategy has
been to replace the surgical incisions with linear lines of
ablation made by mans of various energy sources, including
RF, cryoablation, microwave, ultrasound, and laser ener-
gy.24,25 Elimination of the extensive cutting and sewing
needed to make the atrial incisions of the CMP gives these
new operations the potential to simplify the procedure and
decrease the time of surgery. The hope is that this will
reduce morbidity, encourage referrals, and speed the adop-
tion of this operation by surgeons.
Many groups also have chosen to omit many of the
incisions of the Cox maze procedure. This has made inter-
pretation clinical results difficult, because failure could be
due either to inadequate ablation technology or to an inad-
equate lesion set. It was our goal to perform all the basic
lesions of the CMP but to replace many of the incisions with
lines of ablation.
Our group has concentrated on a device that uses bipolar
RF ablation. By measuring the fall in tissue conductance,
this device was shown to have a definitive and verifiable end
13-15
after modified CMP.m AFpoint of transmurality. Mean ablation times were al-
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lesions were only 1 to 3 mm in width. This was an improve-
ment relative to the width of lesions and time required for
ablation with unipolar devices. This report represents our
first clinical series with this device and details our operative
technique and early clinical results. The safety of this tech-
nology for pulmonary vein isolation was evaluated by MRI
scans at 1 month.
Our modification of the CMP replaced more than half of
the surgical incisions with bipolar ablation lines. This sim-
plified procedure has a single long left atriotomy and only
two right atrial incisions. Isolation of the pulmonary veins
can be performed on the beating heart before crossclamping.
The use of this device decreased mean crossclamp time in
both lone CMP and concomitant CMP groups by more than
30 minutes. However, it should be noted that this compar-
ison is with a historical cohort performed by different sur-
geons, making direct comparison problematic.
This procedure may have other advantages relative to the
cut and sew procedure in addition to its technical simplicity.
With separate isolation of the right and left pulmonary
veins, a significant amount of functioning posterior atrial
myocardium remains, theoretically improving atrial con-
tractility. In the traditional CMP, the right and left pulmo-
nary veins are isolated en bloc, removing virtually all func-
tion of the entire posterior left atrium. Although it is hoped
that such advantages will translate into decreased morbidity,
a much larger cohort of patients will be needed to prove this
hypothesis. There were no operative deaths in this series,
and at 6 months 91% of patients were free from AF, with
only 10 patients requiring antiarrhythmic therapy.
This device was particularly effective in isolating the
pulmonary veins, a key part of any procedure for AF. The
device isolated the right and left pulmonary veins in every
instance. Unfortunately, the device usually required several
applications to isolate the atrial cuff around the pulmonary
veins. We believe that this was due to the large amount of
atrium clamped during this maneuver, which can result in
poor clamp apposition. Experience with the device has
supported not bunching the atria into the clamp to perform
a single ablation, but rather coming across the atrial cuff
from both above and below in cases where there appears to
be excess tissue. Although several ablations were often
required, total combined ablation time for both the right and
left pulmonary veins was under 60 seconds. Isolation was
documented in every instance by pacing. It is our belief that
surgeons who use this technology should routinely use
pacing to confirm isolation.
The question of late pulmonary vein stenosis remains an
important issue. In the electrophysiologic laboratory, there
has been a defined incidence of late pulmonary vein steno-
sis.26,27 Few surgical groups have rigorously evaluated pa-
tients for this problem after RF ablation. In this study, the
540 The Journal of Thoracic and Cardiovascular Surgery ● Octofirst 8 patients were evaluated with high-resolution MRI
scans at 1 month. At that interval there was no evidence of
pulmonary vein stenosis, normal pulmonary vein flow pat-
terns were maintained, and left atrial function was pre-
served.
Preliminary reports from a number of electrophysiologic
laboratories have suggested that pulmonary vein isolation
alone may be curative for selected patients with paroxysmal
AF.28 Although it still remains unclear whether this simple
procedure will be effective in surgical cases, particularly
those of patients with valvular heart disease, this technology
does allow pulmonary vein isolation to be performed
quickly, without the need for any incisions or cardiopulmo-
nary bypass.
The use of bipolar RF ablation represents a step toward
a less invasive maze procedure. Results in our research
laboratory have shown that this technology can be effec-
tively used on the beating heart.14 If the excellent early
results of the modified Cox maze procedure stand the test of
time, the indications for this operation should be expanded.
In our own practice, we believe that the operation is a viable
alternative to a lifetime of anticoagulation for young pa-
tients with solitary AF. Moreover, this simplified operation
should be offered to all patients undergoing valvular surgery
with concomitant AF.
This study has limitations. It represents a relatively small
number of patients with short follow-up. Pulmonary vein
stenosis was evaluated at 1 month, which may be too short
an interval to pick up this complication. Careful long-term
observation will be needed to demonstrate the late efficacy
of this new modification of the CMP. The strengths of this
study are that it is a prospective study of a consecutive
group of patients with 100% follow-up. It is the only study
to date to examine postoperative pulmonary vein stenosis
after bipolar RF ablation. In summary, this study suggests
that bipolar RF ablation is safe and can effectively replace
the surgical incisions of the CMP.
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Discussion
Dr Roger C. Millar (Salt Lake City, Utah). Dr Damiano and I
have a similar interest in the AF problem that dates back really to
Dr Cox, who was a predecessor of both of us at Duke University.
Nine months ago we became interested in this same energy
device, the bipolar RF, and have performed 35 cases, all concom-
itant procedures. Eighty-six percent had mitral valve surgery. In
that group we had 3 triple valves and 16 double valves. You have
averaged 3.2 and 3.3 applications on the pulmonary veins on the
right or the left to prove transmurality by atrial pacing, or techni-
cally really pulmonary vein pacing. Why do you think this is, and
why do you think you required three applications to obtain com-
plete isolation of the pulmonary veins?
Dr Damiano. That’s an absolutely excellent question. Part of it
has been the learning curve with the technology. First of all, we
basically are trying to replicate our animal work, where we would
try in just one clamp to try to bunch all the pulmonary veins into
what is only a 5-cm long clamp and take a big cuff of left atrium,
because we were trying to make sure we didn’t see any pulmonary
vein stenosis. What we have learned and what I think is happening
is that if you bunch what is actually quite a bit of atrial tissue into
this clamp that if you get any type of folding over of the tissue and
any air in there, because air is an incredibly great insulator, you
will get a false high reading of tissue resistance, with the inverse
of that being a low reading of the conductance. That will, I think
in human subjects give you a false-positive indication. It is actually
a real indication that conductance has fallen to a stable minimum,
but that is probably due to having some air or bunched up tissue in
the clamp. What we have gone to in the last group of patients is
that if the actual width of those pulmonary veins is more than 2
thirds of the clamp width, in which the electrode length is 5 cm, we
will then clamp the right superior and inferior and the left superior
and inferior veins separately, or we will take clamps that go from
both below and above. So by definition, you would have to have
two clamps. By doing that we virtually always have conduction
block after just two applications, but certainly in the beginning we
had as many as five applications before we had complete conduc-
tion block. I would say that I certainly believe because of that that
it is absolutely mandatory if you are using this technology to pace
or record pulmonary vein electrograms to document that you have
pulmonary vein isolation, because one would certainly consider
that among the most important parts of any surgical treatment of
AF.
Dr Millar. That seems to imply, then, that we need to be doing
this on the beating heart, at least so we can test transmurality
before proceeding with the other connecting lesions in the left
atrium.
When you are doing your linear lesions to connect the pulmo-
nary veins across the base of the left atrium, or even on the right
side the superior to inferior vena cava longitudinal lesion that we
construct with the bipolar device, do you do more than one burn in
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Dr Damiano. Usually not. I usually just do one burn. You can
directly observe the ablation, and what we have learned in a couple
of years of animal experimentation with this is that if you have
uniformly thick tissue and encompass it without any bunching in
this device, it is virtually 100% reliable in terms of creating a
transmural lesion. If for any reason I am going over any type of
tissue that appears to be a bit nonhomogeneous in terms of its
thickness, to do a second ablation line doesn’t take long. If I have
any question in my mind, a lot of times I will put two ablation lines
right there and still be done in 10 or 15 seconds. Generally for the
other lines, we will perform simply one; especially along the right
atrial free wall and in the posterior left atrium, the tissue is almost
always very uniform in thickness, and usually just one ablation line
is used in those areas.
Dr Millar. Related to this same issue, when I have placed a
second burn, I have usually released the clamp and then reapplied
it. It still takes almost the same amount of time. If this is full
thickness to start with, why does it take several seconds again?
Why, if it was transmural the first time, does it take time to signal
transmurality?
Dr Damiano. The only explanation I can think of is if there is
any moisture that would slip in after your ablation. Basically, the
low conductance is due to a complete desiccation of the tissue. If
you stop, perhaps there is some leeching in of interstitial fluid
which you then have to boil off again. I probably would take that
up with some of the engineers at the company. That is an inter-
esting observation. I have never really tried that myself.
Dr Millar. Try it some time. I really can’t explain it either, but
that’s my best explanation as well. Dr Gillinov presented a series
of 190 patients undergoing left-sided procedures only and showed
a 6-month 80% success rate. I noticed that in your series more than
half of your patients had paroxysmal AF. Would pulmonary vein
isolation and left atrial appendage removal also have given you an
80% success rate? What does that imply for the possible future
application of such a device to do pulmonary vein isolation and left
atrial appendage removal in less than 10 minutes? That could
easily be added to any kind of left-sided operation you are doing.
Would you speculate on the future?
Dr Damiano. I will speculate on the role of pulmonary vein
isolation, both today and in the future. Certainly, there are pro-
vocative electrophysiologic data indicating that pulmonary vein
isolation may be effective treatment for paroxysmal AF. I would
caution all surgeons that the data from Dr Haissaguerre’s labora-
tory in Bordeaux, from Dr Chen’s laboratory in Taiwan, from the
group in Michigan, and from Dr Morady that have justified that
rapid conclusions are virtually all in patients without structural
heart disease and very small left atria. So the role of pulmonary
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mined by our surgical results and not necessarily by what has been
reported in the electrophysiology literature. I think it is still a
hypothesis and that we need to design good clinical studies to
answer this. Clearly, with this device total ablation time to isolate
both sides of the pulmonary vein was less than a minute. It can
dissect, and the dissection of both the left and right sides can be
performed in a couple of minutes each once you are used to doing
it. We do perform this on the beating heart before crossclamping,
as you have suggested, so that we can pace, and that would
probably only add 5 minutes to the operation. I think that you have
to amputate the left atrial appendage, although what our success
rate will be in that group is unclear. Dr Gillinov reported a success
rate clearly much lower than our success rate with the maze
procedure. Their latest reported success is about 75%. They do
have a drawback in that most of their patients really have not been
able to be followed up, because they usually come from a long way
off. Thus I don’t think we know their success rate clearly, and I
think we have to look at. Even in this study, I would tell you it is
too soon. I am not sure what our success rate is going to be. It is
promising that we are at 95% at 6 months, but I don’t know what
we will be long term. We have done 10 cases with just pulmonary
vein isolation. This was a highly selected group. Our success rate
at 6 months has only been 50%, although among patients with
paroxysmal AF it was 66%, so I think there is some indication that
there are some patients for whom it is going to work. I think we
need to get a little bit smarter, and I think we are going to have to
wait for our experience to determine who these patients are. I don’t
think I would jump to the conclusion right now that all patients
with paroxysmal AF who are referred for surgical treatment of AF
should only have pulmonary vein isolation. I think that is a
question remaining to be answered, and I do feel strongly that for
patients who are good candidates for a CMP or a modified proce-
dure like the one I’ve shown today, that’s what you should do. It
historically has a 10-year efficacy rate greater than 90%. Now that
it has been modified with bipolar ablation and some other tech-
nologies, it really does not add significantly to the procedure nor
does it require a lot of lines. I do think that there certainly is going
to be a group of patients who can be successfully treated with
pulmonary vein isolation. I just heard a report from Dr Nitta’s
group in Tokyo, where they have done intraoperative mapping;
they found the patients with pulmonary vein foci—interestingly
not all patients with paroxysmal AF, but about 60% to 70% of
those patients—underwent pulmonary vein isolation with excel-
lent results. So that may be where we are going in the future.
Certainly I think that in those cases it will play a large role and
probably can be done in a minimally invasive and rapid manner by
surgeons.
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